![(−)-3,4,4a,5,6,10b-Hexahydro-9-methoxy-2H-naphtho[1,2-b][1,4]oxazin-3-one - chemical structure image](https://media.scbt.com/product/3-4-4a-5-6-10b-hexahydro-9-methoxy-2h-naphtho1-2-b1-4oxazin-3-one-structure_26_21_b_262151.jpg)
![(−)-3,4,4a,5,6,10b-Hexahydro-9-methoxy-2H-naphtho[1,2-b][1,4]oxazin-3-one - chemical structure image](https://media.scbt.com/product/3-4-4a-5-6-10b-hexahydro-9-methoxy-2h-naphtho1-2-b1-4oxazin-3-one-structure_26_21_t_262151.jpg "(-)-3,4,4a,5,6,10b-Hexahydro-9-methoxy-2H-naphtho[1,2-b][1,4]oxazin-3-one 의 분자 구조")
(-)-3,4,4a,5,6,10b-Hexahydro-9-methoxy-2H-naphtho[1,2-b][1,4]oxazin-3-one 의 분자 구조
(-)-3,4,4a,5,6,10b-Hexahydro-9-methoxy-2H-naphtho[1,2-b][1,4]oxazin-3-one
적용:
(−)-3,4,4a,5,6,10b-Hexahydro-9-methoxy-2H-naphtho[1,2-b][1,4]oxazin-3-one is a dopaminergic antagonist
분자량:
233.26
분자식:
C13H15NO3
연구용으로만 사용가능합니다. 진단이나 치료용으로 사용불가합니다.
* Refer to Certificate of Analysis for lot specific data.
빠른 링크
주문정보
설명
기술정보
안전정보
SDS 및 분석 증명서
(-)-3,4,4a,5,6,10b-Hexahydro-9-methoxy-2H-naphtho[1,2-b][1,4]oxazin-3-one 참고자료
Dijkstra, D., et al.: J. Med. Chem., 45, 3022 (2002)주문정보
| 제품명 | 카탈로그 번호 | 단위 | 가격 | 수량 | 관심품목 | |
(-)-3,4,4a,5,6,10b-Hexahydro-9-methoxy-2H-naphtho[1,2-b][1,4]oxazin-3-one, 5 mg | sc-216587 | 5 mg | $300.00 |